Published On: July 20 , 2021Categories: Congress

Around 600 experts to meet at the 3rd Interdisciplinary Congress on Human Genetics

The main topics at this face-to-face congress include new advances in hereditary cancer, bioinformatics and digital health.

The Congress will be held from 3 to 5 November

The Valencia Conference Centre is soon to host the 3rd Interdisciplinary Congress on Human Genetics, in which around 600 experts will be meeting in person over three days to discuss the latest developments in this field.

The main topics of this scientific and medical congress centre on breakthroughs in hereditary cancer, systems biology, bioinformatics and digital health and their impact on healthcare, precision medicine in the digital society and new genomics in prenatal diagnosis, which will be showcased in various symposia, workshops and conferences. There will also be a debate on essential pharmacogenetic resources and on the strategy for implementing pharmacogenetics in rare diseases.

After holding the two previous congresses in Madrid, this time the city of Valencia has been chosen as the venue for the third national congress. In the words of Patricia Ortíz, CEO of Geyseco, the event organiser, “We chose the Valencia Conference Centre because of the spaciousness and versatility of its facilities in these complex times of COVID. We were looking for a large venue that could accommodate the different scenarios and restrictions.”

The congress has been organised by five scientific societies: the Spanish Association of Human Genetics (AEGH), the Spanish Association of Prenatal Diagnosis (AEDP), the Spanish Society of Pharmacogenetics and Pharmacogenomics (SEFF), the Spanish Society of Clinical Genetics and Dysmorphology (SEGCD) and the Spanish Society of Genetic Counselling (SEAGEN). In addition, the Digital Health Association (ASD) and the Spanish Society of Bioinformatics and Computational Biology (SEBiBC) have been invited as guest societies.

If you would like to find out more about the congress, click here.